China’s draft pharmaceutical trial rules aim to balance innovation with drug availability; CAC issues first rules to regulate ...
Jin and Haoyi Sun of Zhong Lun Law Firm discuss the reasons behind, and the implications of, Illumina’s inclusion in China’s ...
China strengthens Anti-Foreign Sanctions Law in response to U.S. restrictions; Chinese firms move production facilities ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback